Results 191 to 200 of about 171,182 (259)

Characterization of alcohol-related seizures in withdrawal syndrome. [PDF]

Epilepsia Open
Kádár BK, Gajdics J, Pribék IK, Andó B, Lázár BA.   +4 more
europepmc   +1 more source

Things We Do for No Reason™: Prescribing gabapentinoids for pain

Journal of Hospital Medicine, EarlyView.
Abstract Gabapentin and pregabalin are among the most frequently prescribed medications in the United States, with gabapentin in the top 10 and pregabalin in the top 100. Despite FDA approval for only select neuropathic conditions, most use is for off‐label pain indications.
Niti G. Patel, David Goese, Steven M. Belknap, Charles L. Madeira, Jeffrey H. Barsuk   +4 more
wiley   +1 more source

Things We Do for No Reason™: Withholding opioids among patients with acute pain and opioid use disorder

Journal of Hospital Medicine, EarlyView.
Abstract Hospitalists care for patients with acute pain who have an opioid use disorder and require pain management. Hospitalists may withhold opioids for acute pain due to a variety of reasons. However, adequate pain management in patients with opioid use disorder, including with opioids, is the standard of care. This piece explains how to best manage
Anna‐Maria South, Susan L. Calcaterra, Marlene Martin   +2 more
wiley   +1 more source

How Savoring Beliefs Sustain Positive Emotion Under Conditions of Job Stress: Affective Mechanisms Linking Job Stress to Burnout in Young Korean Workers

Journal of Employment Counseling, EarlyView.
ABSTRACT This study examined positive emotion as a mediator linking job stress to burnout and tested the moderating role of savoring beliefs among young Korean employees. A total of 510 participants completed measures of job stress, savoring beliefs, positive emotion, and burnout.
Hang‐Shim Lee, Young‐Seok Kim
wiley   +1 more source

Sleep and circadian rhythm activity alterations during adolescence in a mouse model of neonatal fentanyl withdrawal syndrome. [PDF]

Neuroscience
Williams BR, Gamble MC, Singh N, Bryant CD, Logan BA, Logan RW.   +5 more
europepmc   +1 more source

Notes from the Field: Severe Medetomidine Withdrawal Syndrome in Patients Using Illegally Manufactured Opioids - Pittsburgh, Pennsylvania, October 2024-March 2025. [PDF]

MMWR Morb Mortal Wkly Rep
Ostrowski SJ, Tamama K, Trautman WJ, Stratton DL, Lynch MJ.   +4 more
europepmc   +1 more source

Differential Effects of Intrahippocampal Administration of Ceftriaxone on Morphine Dependence and Withdrawal Syndrome in Rats. [PDF]

ACS Omega
Saeedi N, Giahi M, Jaafari Suha A, Azizi H, Janahmadi M, Hosseinmardi N.   +5 more
europepmc   +1 more source

The role of 5-HT modulation in opioid withdrawal and neonatal opioid withdrawal syndrome: mechanisms and potential serotonergic targets. [PDF]

Expert Opin Investig Drugs
Lam K, Peltz G, Kraft WK.
europepmc   +1 more source

Therapeutic Potential of Black Seed and Opium Poppy Oils in Mitigating Morphine Withdrawal Syndrome in an Animal Model. [PDF]

Addict Health
Mirasheh MH, Mashhadi Akbar Boojar M, Saberi M, Zarei SM, Kazemi R.   +4 more
europepmc   +1 more source